• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION SD ALARIS PC UNIT; PUMP, INFUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION SD ALARIS PC UNIT; PUMP, INFUSION Back to Search Results
Model Number 8015
Device Problem Excess Flow or Over-Infusion (1311)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/12/2020
Event Type  Injury  
Manufacturer Narrative
The customer¿s report of medication infusing faster than programming was due to the user programming an infusion at an unintended custom concentration.¿on (b)(6) 2020 at 7:18 am and at 8:20 am the user programmed an infusion of sufentanil (drugid 463) with a 20ml syringe and a drug amount of 100mcg in diluent 100ml (instead of the intended 20 ml) with a rate of 23.4ml.At 8:50 am the user entered a dose 0.25mcg/kg/h which adjusted the rate to 19.5ml/h.¿the customer reported that the intended rate was 7.86ml/hr making the programmed rates approximately 2x and 3x over infusions.¿no errors or malfunctions were recorded in the syringe module error logs on the customers reported incident date of (b)(6) 2020.¿functional testing found the as received syringe module passing, plunger force accuracy, barrel clamp accuracy test and plunger position accuracy test.The root cause of the customers report of the medication infused faster than programmed was due to user programing (custom concentration).No device malfunction is believed to have occurred.Review of the pcu s/n (b)(4) service history record showed the device had a manufacture date of 09/16/2019.A review of the device service history record was performed beginning from the date of manufacture to the present date 10/19/2020 and indicated that this device has not been previously returned for service.Review of the production failure record was performed beginning from the date of manufacture through present.The failure record showed no production failure records were opened for the source device.
 
Event Description
It was reported that the clinician mixed 100mcg sufentanil into 20ml of fluid (5mcg/ml) and programmed the syringe pump to infuse at a rate of 0.5 mcg/kg/hr = 7.86ml/hr, however the medication infused faster than programmed "after a short time." the nurse re-programmed the pump with the same concentration to infuse another 100mcg, which also infused too quickly, at which point the clinician noted the error.The patient's electronic medical record (emr) epic indicated that a total of 50mcg had been delivered to the patient, however the patient had actually received a total of 200mcg.The clinician then corrected the dosing documentation in epic to reflect the true amount administered to the patient.Due to the event, the patient required additional oxygen monitoring overnight and a prolonged pacu stay, however the patient did not require any additional medical intervention to preclude serious injury.There was no patient harm.
 
Manufacturer Narrative
Revised to a serious injury, aware date of (b)(6) 2020.*******************************************************************************************.
 
Event Description
It was reported that the clinician mixed 100mcg sufentanil into 20ml of fluid (5mcg/ml) and programmed the syringe pump to infuse at a rate of 0.5 mcg/kg/hr = 7.86ml/hr, however the medication infused faster than programmed "after a short time." the nurse re-programmed the pump with the same concentration to infuse another 100mcg, which also infused too quickly, at which point the clinician noted the error.The patient's electronic medical record (emr) epic indicated that a total of 50mcg had been delivered to the patient, however the patient had actually received a total of 200mcg.The clinician then corrected the dosing documentation in epic to reflect the true amount administered to the patient.Due to the event, the patient required additional oxygen monitoring overnight and a prolonged pacu stay, however the patient did not require any additional medical intervention to preclude serious injury.There was no patient harm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS PC UNIT
Type of Device
PUMP, INFUSION
Manufacturer (Section D)
CAREFUSION SD
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key10823445
MDR Text Key227207097
Report Number2016493-2020-31928
Device Sequence Number1
Product Code FRN
UDI-Device Identifier10885403801518
UDI-Public10885403801518
Combination Product (y/n)N
PMA/PMN Number
K133532
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,other
Type of Report Initial,Followup
Report Date 06/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number8015
Device Catalogue Number8015
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/06/2020
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/11/2020
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received11/12/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SYRTUBE, THERAPY DATE 06/12/2020
Patient Outcome(s) Hospitalization; Other;
Patient Age26 YR
Patient Weight78
-
-